Diagnostic insights into chronic-inflammatory demyelinating polyneuropathies.

Area of Science:

• Neurology
• Immunology
• Pathology

Background:

• Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare immune-mediated disorder affecting nerve fibers.
• CIDP presents diverse clinical phenotypes and treatment responses, complicating diagnosis.
• Current serological diagnostic markers for CIDP are insufficient compared to acute neuropathies.

Purpose of the Study:

• To review advancements in autoantibody testing for CIDP diagnosis.
• To explore the potential of autoantibodies in stratifying CIDP variants.
• To assess the role of autoantibodies in predicting treatment response.

Main Methods:

• Literature review of studies on autoantibody testing in CIDP.
• Analysis of autoantibodies targeting glycolipids and nodal/paranodal molecules.
• Evaluation of electrophysiological and morphological diagnostic markers.

Main Results:

• Autoantibodies are emerging as promising candidate markers for CIDP diagnosis.
• Specific autoantibodies may help differentiate CIDP variants.
• Autoantibody profiles could aid in patient stratification for targeted therapies.

Conclusions:

• Autoantibody testing shows significant potential for improving CIDP diagnosis and classification.
• Further research is needed to fully integrate autoantibody testing into clinical practice for CIDP.
• Autoantibodies may refine treatment strategies and predict patient outcomes in CIDP.